White Muscle Disease

White muscle disease, also known as nutritional muscular dystrophy or stiff lamb disease, is a degenerative condition of skeletal and cardiac muscle caused by deficiency of selenium and vitamin E in sheep. This condition primarily affects young lambs, causing muscle weakness, stiffness, and in severe cases, sudden death from cardiac involvement. The disease derives its name from the characteristic pale, chalky appearance of affected muscles seen during post-mortem examination, reflecting the degeneration and calcification of muscle fibers. White muscle disease represents one of the most economically significant nutritional diseases in sheep production, particularly in geographic regions where soils are naturally deficient in selenium.

The relationship between selenium, vitamin E, and muscle health centers on their roles as antioxidants that protect cell membranes from oxidative damage. Selenium functions as a component of glutathione peroxidase, an enzyme that neutralizes harmful peroxides generated during normal cellular metabolism. Vitamin E acts directly as a membrane-associated antioxidant. When both nutrients are deficient, muscle cells cannot protect themselves from oxidative stress, leading to membrane damage, calcium influx, and ultimately cell death. The rapidly metabolizing muscles of growing lambs are particularly vulnerable because their high metabolic rates generate substantial oxidative stress.

The geographic distribution of white muscle disease correlates strongly with soil selenium levels, which vary dramatically worldwide and even across relatively small distances. Regions with notably low selenium include parts of New Zealand, Scandinavia, Australia, and extensive areas of North America including the Pacific Northwest, Great Lakes region, and portions of the eastern United States. Volcanic soils, heavily weathered soils, and high-rainfall areas tend to have lower selenium availability. Understanding regional selenium status is essential for sheep producers, as prevention programs must be tailored to local conditions.

The economic impact of white muscle disease on affected flocks can be substantial, including direct mortality, reduced growth rates in subclinically affected animals, and decreased reproductive performance. Lambs that survive severe episodes may have permanent muscle damage that impairs mobility and productivity. However, the condition is highly preventable through appropriate supplementation of pregnant ewes and young lambs. The dramatic effectiveness of prevention programs means that white muscle disease, while potentially devastating, is increasingly a disease of management oversight rather than an unavoidable production challenge.

The primary cause of white muscle disease is deficiency of selenium, often combined with inadequate vitamin E status, during critical periods of muscle development. Selenium deficiency occurs when sheep consume forages or feeds grown on selenium-deficient soils without appropriate supplementation. The selenium content of plants directly reflects soil selenium levels and bioavailability, creating geographic hotspots of deficiency. Forages containing less than 0.1 parts per million selenium on a dry matter basis are considered deficient and incapable of meeting sheep requirements without supplementation. Vitamin E deficiency can develop independently or in combination with selenium deficiency, particularly when animals consume harvested feeds stored for extended periods, as vitamin E degrades during storage.

No direct genetic predisposition to white muscle disease exists, as the condition results from nutritional deficiency rather than inherited metabolic defects. However, lambs with higher growth rates and greater muscle mass may be more severely affected because their selenium requirements exceed those of slower-growing animals. Twin and triplet lambs face higher risk than singles because maternal selenium stores must be shared among multiple fetuses. Some research suggests that certain blood selenium-binding proteins vary among individuals, potentially affecting selenium utilization efficiency, though this is not well established as a practical risk factor.

Environmental and management factors significantly influence white muscle disease risk beyond regional soil selenium status. Intensive grazing systems that rely heavily on harvested feeds rather than fresh pasture may face higher risk due to vitamin E losses during hay and grain storage. Pregnant ewes with limited access to selenium-adequate pastures or feeds have depleted body stores, resulting in selenium-deficient lambs at birth. Lush, rapidly growing spring pastures may be lower in selenium than more mature growth. Certain soil amendments and fertilization practices can affect selenium uptake by plants, potentially improving or worsening the situation depending on specifics.

Risk factors for white muscle disease include young age, rapid growth, high dietary polyunsaturated fatty acid content, and any condition increasing oxidative stress. Newborn lambs and those in the first weeks of life are most vulnerable because their selenium stores depend entirely on maternal transfer during pregnancy and through colostrum and milk. Stressors including cold weather, transport, handling, and concurrent disease increase selenium requirements while potentially reducing intake. Dietary factors that promote oxidation, including rancid fats and high iron content, increase vitamin E requirements and can precipitate clinical disease in marginally deficient animals.

The pathophysiology of white muscle disease involves failure of antioxidant defense systems leading to oxidative damage of muscle cell membranes. Without adequate selenium-dependent glutathione peroxidase and vitamin E, reactive oxygen species accumulate and attack polyunsaturated fatty acids in cell membranes. This lipid peroxidation damages membrane integrity, allowing uncontrolled calcium entry into muscle cells. Elevated intracellular calcium triggers sustained muscle contraction and activates destructive enzymes that cause further cellular damage. The result is muscle fiber necrosis with characteristic microscopic findings of hyaline degeneration, fragmentation, and calcification. Both skeletal muscles involved in movement and cardiac muscle can be affected, with cardiac involvement explaining the sudden deaths that occur in some cases.

Early warning signs of white muscle disease in lambs may be subtle and easily attributed to other causes. Affected lambs may nurse less vigorously or have slightly slower growth rates than their cohorts. Mild stiffness after rest that resolves with movement can be an early indicator. Lambs may lag behind the flock during movement or tire more quickly than normal. In very young lambs, reluctance to stand or difficulty rising after lying down may be the first observable abnormality. These early signs often precede more obvious clinical disease by days to weeks, and their recognition enables early intervention that significantly improves outcomes.

The classic presentation of white muscle disease involves pronounced muscle stiffness and weakness, giving rise to the common name stiff lamb disease. Affected lambs have a stiff, stilted gait with obvious difficulty flexing their limbs normally. They may walk on their toes with an arched back posture due to involvement of back and hindquarter muscles. Severe cases may be unable to stand at all, lying with legs extended rigidly. The muscle groups most commonly affected include those of the hindquarters, back, and shoulders, though distribution varies among individuals. When the tongue and throat muscles are involved, difficulty nursing and swallowing may be prominent.

Behavioral changes associated with white muscle disease reflect the physical limitations and discomfort of affected lambs. Weak lambs separate from the flock because they cannot keep pace with normal movement. They spend excessive time lying down and may need assistance to stand for nursing. Despite muscle weakness, affected lambs typically remain bright and alert and maintain appetite if physically able to nurse. Progressive deterioration in mobility over days indicates ongoing muscle damage. Some lambs become increasingly distressed as their condition worsens, particularly if unable to reach the ewe to nurse.

Physical examination findings in white muscle disease include palpably firm, swollen muscles that may be painful when handled. The affected muscles feel doughy or woody compared to the soft, pliable muscles of normal lambs. Muscle tremors may be visible, particularly when the lamb attempts movement or when muscles are palpated. Heart sounds may reveal arrhythmias or murmurs if cardiac muscle is involved. Respiratory rate may be elevated from the effort of breathing with compromised intercostal muscles or from cardiac compromise. Body temperature is typically normal unless secondary complications develop.

Symptom progression in white muscle disease varies depending on the severity of deficiency and the muscle groups involved. Mild cases may show only transient stiffness that resolves with treatment. Moderate cases progress from initial stiffness to more pronounced weakness over several days if untreated. Severe cases, particularly those with cardiac involvement, may progress rapidly to recumbency and death within hours to days. The cardiac form can cause sudden death without prior obvious clinical signs, as even modest cardiac muscle damage can trigger fatal arrhythmias. Lambs that survive severe episodes may have permanent muscle damage affecting their mobility and productivity.

Emergency symptoms requiring immediate intervention include sudden collapse, severe respiratory distress, complete inability to rise, and evidence of cardiac dysfunction. Lambs found dead without prior signs of illness should prompt consideration of white muscle disease, particularly in selenium-deficient regions. Multiple affected lambs within a flock indicate a flock-wide problem requiring immediate supplementation of all animals. Any lamb showing progressive weakness over hours rather than days may be experiencing cardiac involvement warranting urgent treatment. Severe dysphagia preventing nursing creates immediate nutritional compromise requiring supplemental feeding.

Clinical examination for suspected white muscle disease evaluates the pattern and severity of muscle involvement alongside the animal's signalment and history. The veterinarian assesses gait, ability to rise and stand, and muscle tone and consistency through palpation. Cardiac auscultation may reveal arrhythmias or abnormal heart sounds suggesting myocardial involvement. The age of affected lambs, their dietary history, and regional selenium status provide context supporting or refuting the diagnosis. Examination of multiple affected animals helps establish whether the presentation is consistent with a nutritional deficiency affecting the group rather than individual animal problems.

Diagnostic testing for white muscle disease includes both confirmation of selenium and vitamin E deficiency and documentation of muscle damage. Blood selenium levels directly reflect current status, with values below 0.05 parts per million indicating severe deficiency. Glutathione peroxidase activity in blood provides a functional measure of selenium status over time. Vitamin E levels can be measured in serum or plasma. Serum muscle enzymes, particularly creatine kinase and aspartate aminotransferase, are markedly elevated in acute cases due to muscle cell breakdown. Post-mortem examination reveals the characteristic pale, chalky white streaks in affected muscles that give the disease its name, with histopathology confirming hyaline degeneration and calcification.

Differential diagnosis for white muscle disease includes other conditions causing weakness or stiffness in young lambs. Hypothermia and starvation cause weakness but typically affect overall condition and responsiveness rather than producing the specific muscle stiffness of white muscle disease. Joint ill causes lameness with obvious joint swelling and heat. Spinal cord disease from trauma or abscess causes hindlimb weakness without the characteristic muscle changes. Congenital abnormalities may cause movement problems from birth. Tick paralysis produces ascending paralysis with a different distribution and progression. The combination of characteristic muscle findings, elevated muscle enzymes, low selenium status, and appropriate geographic and dietary history confirms white muscle disease.

Herd-level diagnostics for white muscle disease help characterize flock selenium status and guide prevention programs. Testing a sample of ewes for blood selenium before lambing identifies flocks at risk. Liver selenium concentrations from necropsy samples or biopsy provide longer-term status assessment than blood levels. Forage testing reveals whether pastures and hay are selenium-deficient. Soil testing helps explain regional patterns and guides decisions about selenium fertilization. Systematic evaluation of feeding programs identifies gaps in mineral supplementation that may have contributed to the outbreak.

Emergency and immediate treatment for white muscle disease involves injectable selenium and vitamin E preparations administered as soon as the diagnosis is suspected. Combination products containing both nutrients are widely available and preferred for initial treatment. The injection should be given intramuscularly in the neck or hindquarter, with dosing according to product labeling based on body weight. Response to treatment in skeletal muscle cases can be dramatic, with visible improvement in mobility within twenty-four to forty-eight hours. Severely affected lambs may require multiple treatments over several days. Cardiac involvement carries a more guarded prognosis, as damaged heart muscle cannot regenerate, though stabilization of remaining function may occur.

Medical management of white muscle disease continues beyond emergency treatment to correct the underlying deficiency and prevent relapse. Oral selenium supplementation can be provided through drenches or selenium-containing pastes, though absorption is less reliable than injectable routes. The ewe's selenium status should be addressed through supplementation to improve milk selenium content for nursing lambs. Vitamin E supplementation can be provided through injectable preparations or high-vitamin E feeds. Treatment duration depends on the severity of deficiency and the remaining risk period, with ongoing supplementation often needed until lambs are established on adequate feed sources.

Surgical intervention is not applicable to white muscle disease, as the condition does not produce lesions amenable to surgical correction. Management is entirely medical and nutritional. However, supportive physical care for recumbent lambs includes soft bedding, repositioning to prevent pressure sores, and assisted standing to encourage circulation and muscle function recovery.

Supportive care for white muscle disease addresses the consequences of muscle weakness while treatment takes effect. Lambs unable to nurse effectively require supplemental feeding through bottle or tube to maintain nutrition and hydration. Warmth and shelter prevent hypothermia in compromised lambs. Protecting weak lambs from trampling by other animals and from predation addresses their vulnerability during recovery. Physical therapy through gentle manipulation and supported standing may help maintain muscle function in recovering animals. Monitoring for secondary complications including aspiration pneumonia and pressure sores enables prompt intervention.

Herd treatment protocols following white muscle disease cases extend treatment and prevention to all at-risk animals. All lambs in the affected group should receive preventive selenium and vitamin E injections regardless of current clinical status. Pregnant and lactating ewes should receive supplementation appropriate to their production stage. Mineral programs should be immediately reviewed and corrected if inadequate. All sheep on the operation should receive appropriate supplementation as determined by veterinary consultation. The goal is preventing additional cases while addressing the underlying flock deficiency.

Treatment decisions for white muscle disease consider the expected response to therapy and the value of affected animals. The condition is highly treatable when detected before extensive cardiac damage occurs, making aggressive treatment of skeletal muscle cases generally worthwhile. Lambs with severe cardiac involvement have guarded prognoses and may not survive despite treatment, requiring honest assessment of the situation. Mildly affected lambs have excellent prognoses with prompt treatment. The highly preventable nature of the disease means that resources should be directed toward both treatment of current cases and prevention of future cases through improved supplementation programs.

Recovery timeline for white muscle disease varies with the severity of muscle damage and the promptness of treatment. Lambs with mild skeletal muscle involvement treated early often show improvement within twenty-four to forty-eight hours, with full recovery over one to two weeks. Moderate cases may require several days to weeks for significant improvement, with some residual stiffness persisting longer. Severe skeletal muscle cases can recover with intensive supportive care but may have permanent weakness or deformity from muscle fibrosis. Cardiac muscle damage does not regenerate, so lambs surviving cardiac involvement may have permanently reduced exercise tolerance and be at risk for sudden death during exertion.

Post-treatment care and monitoring for white muscle disease survivors emphasizes ongoing nutritional support and observation for complications or recurrence. Selenium and vitamin E supplementation should continue according to veterinary recommendations, with follow-up testing to confirm adequate status. Body condition and growth rate monitoring ensures recovering lambs are thriving. Activity should be gradually increased as mobility improves to prevent reinjury of weakened muscles. Lambs that required prolonged recumbency need monitoring for pressure sores, respiratory complications, and secondary infections.

Prognosis factors for white muscle disease include the form of disease, duration before treatment, and severity of muscle damage at presentation. Pure skeletal muscle cases have excellent prognoses with early treatment. Cardiac involvement significantly worsens prognosis, with some affected lambs dying despite treatment. Duration of clinical signs before treatment correlates with muscle damage extent and recovery completeness. Lambs that remain standing throughout their illness generally recover more fully than those that become recumbent. Adequate ongoing nutrition and appropriate selenium status support recovery and prevent relapse.

Return to production considerations for white muscle disease survivors account for any permanent deficits from muscle damage. Most lambs recovering from mild to moderate skeletal muscle disease achieve normal growth and can be marketed or retained as breeding stock without restriction. Severely affected lambs may have reduced growth rates and inferior carcass quality from muscle damage. Lambs with known or suspected cardiac involvement should not be retained for breeding due to risk of sudden death and should be marketed at appropriate weights rather than pushed for maximum growth. Ewes that produced affected lambs should have their selenium status optimized before subsequent breeding.

Vaccination protocols are not applicable to white muscle disease prevention because the condition results from nutritional deficiency rather than infection. However, the parallel preventive approach of strategic supplementation functions analogously to vaccination in providing protection before disease occurs. Selenium supplementation of ewes before and during pregnancy ensures adequate fetal selenium stores. Lamb supplementation at birth or during processing provides direct protection during the highest-risk period. The systematic, scheduled approach to supplementation mirrors the strategic timing of vaccination programs.

Biosecurity measures are not directly relevant to white muscle disease as a non-infectious condition. However, quarantine and assessment of incoming animals' nutritional status helps maintain consistent flock management. Animals introduced from selenium-adequate regions may have higher stores than the resident flock, or conversely, animals from severely deficient areas may be at acute risk. Evaluation of selenium status in new animals guides integration into existing supplementation programs.

Nutritional prevention of white muscle disease is the cornerstone of control and involves ensuring adequate selenium and vitamin E intake throughout the production cycle. Multiple supplementation methods are available including selenium-fortified mineral mixes, selenium boluses that lodge in the forestomachs and release slowly, injectable selenium preparations, and selenium fertilization of pastures. Vitamin E supplementation through injectable preparations or high-vitamin E feeds complements selenium provision. The optimal approach depends on regional deficiency severity, management system, and producer preference. Most operations in deficient areas require multiple complementary approaches to achieve reliable prevention.

Management practices for white muscle disease prevention center on identifying risk status and implementing appropriate supplementation. Understanding regional selenium status through soil maps, forage testing, and historical disease occurrence guides baseline prevention intensity. Timing supplementation to cover critical periods, particularly late pregnancy and early lamb life, maximizes protective effect. Ensuring access to mineral supplements for all animals rather than just dominant individuals maintains consistent intake. Record keeping of supplementation dates and products used supports program consistency across years.

Quarantine and testing protocols for white muscle disease prevention focus on monitoring rather than isolation. Regular testing of blood selenium in representative animals confirms that supplementation programs are achieving adequate status. Testing ewes in mid to late pregnancy verifies that fetuses will be born with adequate stores. Testing lambs before weaning confirms that supplementation protocols for young animals are effective. Any clinical cases despite supplementation should prompt testing to identify gaps in the prevention program. Systematic monitoring enables continuous improvement of prevention protocols.

Daily management and monitoring for white muscle disease prevention in selenium-deficient regions requires ongoing attention to mineral supplementation. Free-choice mineral feeders should be regularly checked and refilled to ensure continuous access. Observation of mineral consumption patterns helps identify if intake is adequate or if placement or palatability issues are limiting access. During lambing season, close observation of all lambs for early signs of weakness or stiffness enables prompt treatment. Particular attention to fast-growing lambs, multiples, and lambs from first-pregnancy ewes identifies the highest-risk individuals for early intervention.

Housing and environmental management for white muscle disease prevention emphasizes maintaining access to selenium-containing supplements under all conditions. Mineral feeders should be positioned where all animals can access them without dominance interference. Indoor housing areas need mineral access equally with pasture systems. Protection of mineral supplements from weather prevents deterioration and maintains palatability. Strategic placement of supplements near water and feeding areas encourages regular consumption. In selenium-deficient regions, environmental management cannot substitute for direct supplementation because soil amendment effects on selenium availability are variable and slow.

Herd health programs in selenium-deficient regions should incorporate white muscle disease prevention as a foundational element. The program should specify selenium supplementation methods, products, timing, and animals covered. Pre-breeding supplementation of ewes, pre-lambing boosters, and lamb treatment protocols should be documented and consistently implemented. Annual review of the supplementation program with a veterinarian ensures protocols remain appropriate as management changes. Integration with other nutritional management creates comprehensive mineral programs addressing multiple potential deficiencies.

Record keeping and monitoring for white muscle disease prevention documents supplementation activities and any clinical cases despite prevention efforts. Individual animal records in small flocks or group treatment records in larger operations track when animals received selenium supplementation. Cases of white muscle disease should prompt investigation of what went wrong with prevention, including verification that affected animals actually received supplementation. Tracking lamb mortality and growth performance over time reveals whether subclinical deficiency may be affecting productivity even without obvious clinical disease.

Economic considerations for white muscle disease prevention strongly favor investment in supplementation over treatment of clinical cases. Selenium supplementation costs are minimal compared to the value of lambs protected, even when including injectable preparations for ewes and lambs in addition to mineral mixes. The cost of a single lamb death far exceeds a year of supplementation for the entire flock. Subclinical deficiency effects on growth and reproduction represent additional losses that supplementation prevents. In severely deficient regions, selenium fertilization of pastures may be economically justified as a long-term improvement to the forage base.

High-risk breeds for white muscle disease include those with high growth rates and muscular conformation that increase selenium requirements. Fast-growing terminal sire breeds such as Suffolk, Hampshire, and Texel produce lambs with high muscle mass and correspondingly high selenium demands. Dual-purpose breeds selected for both meat and wool may have elevated requirements compared to traditional wool breeds. However, no breed is immune, and all sheep in selenium-deficient regions require appropriate supplementation regardless of genetic background. The risk factors relate more to management and environment than to specific breed susceptibility.

Production type considerations influence white muscle disease risk through their effects on nutritional demands and management intensity. Intensively managed meat production flocks pushing for rapid lamb growth face higher practical risk because fast growth increases selenium requirements. Prolific breeds producing twins and triplets have greater demands during pregnancy and divide maternal selenium among multiple lambs. Show flocks selecting and feeding for maximum muscle may push animals into deficiency despite supplementation programs adequate for less intensively managed stock. Any production system can prevent the disease through appropriate supplementation intensity matched to the demands of the specific operation.

Genetic selection and testing for white muscle disease focus on identifying deficient populations rather than selecting for resistance. All sheep require adequate selenium regardless of genetics, as no meaningful variation in selenium requirements or utilization has been identified for practical selection. Blood or liver selenium testing identifies animals needing supplementation. Selection for productive traits including growth rate and muscling indirectly increases selenium requirements, necessitating corresponding increases in supplementation programs. Breeding programs should ensure that nutritional management keeps pace with genetic improvement in production traits.

Commonly co-occurring conditions with white muscle disease include other manifestations of selenium and vitamin E deficiency affecting different body systems. Retained fetal membranes in ewes correlate with selenium deficiency and may be observed in flocks experiencing lamb white muscle disease. Reduced immune function from deficiency increases susceptibility to infectious diseases including pneumonia and neonatal infections. Poor reproductive performance including infertility and early embryonic death may reflect subclinical deficiency. Ill-thrift syndrome with poor growth despite adequate feed can indicate deficiency affecting productivity without causing obvious clinical disease.

Conditions with similar symptoms to white muscle disease require careful differentiation. Hypothermia and starvation cause weakness in young lambs but do not produce the characteristic muscle stiffness or elevated muscle enzymes. Joint ill causes lameness with obvious joint swelling. Tick paralysis produces progressive paralysis with a different clinical course. Congenital myopathies cause weakness from birth with distinct histopathological findings. Copper deficiency can cause weakness but produces distinct lesions and responses to treatment. Spinal abnormalities cause hindlimb dysfunction without the generalized muscle involvement of white muscle disease.

Complications and sequelae of white muscle disease extend beyond the acute episode. Permanent cardiac damage in survivors of myocardial involvement creates ongoing risk of sudden death during exertion or stress. Muscle fibrosis from severe skeletal muscle damage may cause lasting stiffness and reduced mobility affecting productivity. Secondary infections including aspiration pneumonia can develop in recumbent lambs. Nutritional deprivation from inability to nurse causes additional compromise. Pressure sores and muscle damage from prolonged recumbency create additional problems. Even after clinical recovery, lambs may have reduced growth performance reflecting earlier tissue damage.